Matthew Kyle Hillman, DO | |
110 S Apple Blossom Dr, Chelan, WA 98816-8810 | |
(509) 682-3300 | |
Not Available |
Full Name | Matthew Kyle Hillman |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 110 S Apple Blossom Dr, Chelan, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689179236 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | OP61393220 (Washington) | Primary |
Entity Name | Summa Emergency Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811936883 PECOS PAC ID: 4880590876 Enrollment ID: O20031210000579 |
News Archive
Delaying the introduction of potentially allergenic foods until after a baby's first year may increase the likelihood of a food allergy later on, according to new findings from the Canadian Healthy Infant Longitudinal Development Study.
Pfizer has said that the European Patent Office (EPO) has issued an opinion upholding, in its entirety, the company's calcium salt patent covering Lipitor.
The survey was conducted by Liberty Mutual Insurance and Students Against Destructive Decisions (SADD). They looked at 2,300 eleventh and twelfth graders and found more than one-third of teens who have driven after using marijuana say the drug doesn't distract them from driving. What's more, one in five teens admitted to driving high. In addition the survey found 13 percent of teens said they had got behind the wheel after drinking, while 19 percent did not consider drinking a major distraction.
MorphoSys AG announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology".
› Verified 7 days ago
Entity Name | Emergency Medicine Physicians Of Lake County Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154763944 PECOS PAC ID: 0042444051 Enrollment ID: O20131007000784 |
News Archive
Delaying the introduction of potentially allergenic foods until after a baby's first year may increase the likelihood of a food allergy later on, according to new findings from the Canadian Healthy Infant Longitudinal Development Study.
Pfizer has said that the European Patent Office (EPO) has issued an opinion upholding, in its entirety, the company's calcium salt patent covering Lipitor.
The survey was conducted by Liberty Mutual Insurance and Students Against Destructive Decisions (SADD). They looked at 2,300 eleventh and twelfth graders and found more than one-third of teens who have driven after using marijuana say the drug doesn't distract them from driving. What's more, one in five teens admitted to driving high. In addition the survey found 13 percent of teens said they had got behind the wheel after drinking, while 19 percent did not consider drinking a major distraction.
MorphoSys AG announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology".
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew Kyle Hillman, DO 15855 19 Mile Rd, Clinton Township, MI 48038-3504 Ph: () - | Matthew Kyle Hillman, DO 110 S Apple Blossom Dr, Chelan, WA 98816-8810 Ph: (509) 682-3300 |
News Archive
Delaying the introduction of potentially allergenic foods until after a baby's first year may increase the likelihood of a food allergy later on, according to new findings from the Canadian Healthy Infant Longitudinal Development Study.
Pfizer has said that the European Patent Office (EPO) has issued an opinion upholding, in its entirety, the company's calcium salt patent covering Lipitor.
The survey was conducted by Liberty Mutual Insurance and Students Against Destructive Decisions (SADD). They looked at 2,300 eleventh and twelfth graders and found more than one-third of teens who have driven after using marijuana say the drug doesn't distract them from driving. What's more, one in five teens admitted to driving high. In addition the survey found 13 percent of teens said they had got behind the wheel after drinking, while 19 percent did not consider drinking a major distraction.
MorphoSys AG announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology".
› Verified 7 days ago
Dr. Chris Richard Welter, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 503 E Highland Ave, Chelan, WA 98816 Phone: 509-682-3300 |